MIRA Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 11.98 million compared to USD 7.06 million a year ago. Basic loss per share from continuing operations was USD 0.64 compared to USD 0.4 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8182 USD | +2.28% | -7.02% | -22.08% |
29/05 | Sector Update: Health Care Stocks Fall Late Afternoon | MT |
29/05 | Sector Update: Health Care Stocks Retreat Wednesday Afternoon | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.08% | 1.18Cr | |
+43.36% | 5.81TCr | |
-5.31% | 4.05TCr | |
+37.52% | 3.9TCr | |
+14.75% | 2.67TCr | |
-12.56% | 2.66TCr | |
-22.45% | 1.9TCr | |
+0.04% | 1.22TCr | |
+25.12% | 1.2TCr | |
+26.04% | 1.19TCr |
- Stock Market
- Equities
- MIRA Stock
- News MIRA Pharmaceuticals, Inc.
- MIRA Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023